Denosumab

The therapeutic arsenal for osteoporosis has expanded dramatically since the early 1980s, when the only options were estrogen for women and calcium and vitamin D for men. Today, the picture is much different. Available therapies include estrogen, raloxifene, four different bisphosphonates, the anabolics teriparatide and abaloparatide, and the monoclonal antibody denosumab.